The purpose of this study is to determie the status of B vitamins in rheumatoid arthritis (RA) patients with or without methotrexate (MTX) treatment by methionine and tryptophan load tests, and by measuring vitamin B levels in the blood. Recently, we have found that patients with RA and low plasma PLP levels also have elevated homocysteine levels, both fasting and in response to an oral methionine challange, than do healthy subjects. Hyper-homocysteinemia is a newly recognized risk factor for stroke and coronary heart disease, and may be important in explaining the increased mortality rate of patients with RA. We hypothesize that PLP deficiency in RA causes disorders of PLP-dependent metabolic pathways. We hypothesize that MTX blocks the response to the methionine challenge test, but that PLP deficiency nonetheless exists in patients treated with MTX, and that this deficiency can be identified using a tryptophan challenge test. This study will: a. determine the response to methionine and tryptophan challenge in 20 patients with RA taking MTX, 20 patients not taking MTX, and 20 age-matched healthy controls; b. determine the effect of nonsteroidal anti-inflammatory medication on the tryptophan challenge test by re-testing the healthy control subjects after two weeks of treatment with naproxen; c. determine whether there is a level of plasma PLP which can reliably predict vitamin B6 deficiency in patients with RA; d. test the ability of 1 month of oral vitamin B6 therapy to normalize methionine and tryptophan challenge results in those patients with abnormal tests.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Lamon-Fava, Stefania; Diffenderfer, Margaret R; Barrett, P Hugh R et al. (2018) Differential Effects of Estrogen and Progestin on Apolipoprotein B100 and B48 Kinetics in Postmenopausal Women. Lipids 53:167-175
Askie, Lisa M; Darlow, Brian A; Finer, Neil et al. (2018) Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA 319:2190-2201
Dad, Taimur; Abebe, Kaleab Z; Bae, K Ty et al. (2018) Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep 3:619-624
Di Fiore, Juliann M; Martin, Richard J; Li, Hong et al. (2017) Patterns of Oxygenation, Mortality, and Growth Status in the Surfactant Positive Pressure and Oxygen Trial Cohort. J Pediatr 186:49-56.e1
Scherzer, Rebecca; Heymsfield, Steven B; Rimland, David et al. (2017) Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection. AIDS 31:71-79
Torres, Vicente E; Abebe, Kaleab Z; Schrier, Robert W et al. (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91:493-500
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Irazabal, María V; Abebe, Kaleab Z; Bae, Kyongtae Ty et al. (2017) Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. Nephrol Dial Transplant 32:1857-1865
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120

Showing the most recent 10 out of 412 publications